Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
FDA authorizes Regeneron’s Covid drug at lower dose, and in injectable formulation
MedCity News
Sun, 06/6/21 - 10:36 pm
Regeneron
FDA
COVID-19
Emergency Use Authorization
Regeneron resumes enrollment in lymphoma drug trials
Reuters
Mon, 05/17/21 - 11:05 pm
Regeneron
clinical trials
FDA
lymphoma
odronextamab
Regeneron's Evkeeza shows promise in curbing high triglycerides, but will genetic disparities limit use?
Endpoints
Sun, 05/16/21 - 11:30 pm
Regeneron
Evkeeza
high triclycerides
ACC
Pfizer, Regeneron CEOs see extended need for COVID-19 vaccines, treatments as pandemic enters next phase
Fierce Pharma
Tue, 05/11/21 - 10:09 pm
Pfizer
Regeneron
pandemic
COVID-19
vaccines
Pharma CEOs
Albert Bourla
Len Schleifer
Regeneron’s golden goose Eylea may stave off biosimilar competition until 2024 or beyond
Endpoints
Tue, 05/4/21 - 10:39 am
Regeneron
Eylea
biosimilars
macular degeneration
Regeneron CEO Schleifer bags massive $135M payday after 2020 pandemic wins
Fierce Pharma
Mon, 04/26/21 - 11:10 am
Regeneron
Len Schleifer
Pharma CEOs
executive pay
Regeneron looks to inject another $330M into long-running manufacturing expansion plan: report
Fierce Pharma
Sun, 04/25/21 - 01:49 pm
Regeneron
drug manufacturing
New York
Will Regeneron's COVID Cocktail Win Be Short-Lived?
Motley Fool
Wed, 04/21/21 - 10:37 am
Regeneron
antibodies
COVID-19
Regeneron’s Covid mAb as a prophylactic injection: Reduced risk of symptomatic infection by 81%
Endpoints
Mon, 04/12/21 - 11:09 am
Regeneron
monoclonal antibodies
NIH
COVID-19
Regeneron shoots for longer Eylea dosing interval in diabetic retinopathy with NIH data
Fierce Pharma
Fri, 04/2/21 - 10:55 am
Regeneron
FDA
Eylea
diabetic retinopathy
NIH
Could Regeneron's Antibody Therapy Be as Important as Vaccines in Fighting COVID?
Motley Fool
Wed, 03/31/21 - 10:37 am
Regeneron
vaccines
antibodies
COVID-19
Regeneron used Cuomo connections to get R&D chief Yancopoulos early COVID testing: NYT
Fierce Pharma
Fri, 03/26/21 - 10:49 am
Regeneron
George Yancopoulos
Andrew Cuomo
COVID-19
Regeneron and Roche's antibody cocktail shown helping in COVID-19 cases
Reuters
Tue, 03/23/21 - 10:42 am
Regeneron
Roche
clincial trials
COVID-19
Sanofi, Regeneron’s Libtayo improves survival in cervical cancer patients
Pharma Times
Mon, 03/15/21 - 10:48 am
Sanofi
Regeneron
Libtayo
cervical cancer
clinical trials
Libtayo scores second OK in two weeks, this time for front-line NSCLC. Can it take on Keytruda?
Endpoints
Mon, 02/22/21 - 11:51 pm
Regeneron
Libtayo
non-small cell lung cancer
Merck
Keytruda
Novartis’s canakinumab cancer test approaches
EP Vantage
Fri, 02/12/21 - 11:06 am
Novartis
Regeneron
canakinumab
cancer
non-small cell lung cancer
Amgen loses appeal in patent suit against Sanofi/Regeneron’s Praluent. It’s a bummer for Bristol Myers Squibb and Merck, too
Endpoints
Fri, 02/12/21 - 10:48 am
Amgen
patents
Sanofi
Regeneron
Praluent
Repatha
Merck
Regeneron's Evkeeza, carrying big price tag, wins FDA approval in ultra-rare cholesterol disease
Fierce Pharma
Thu, 02/11/21 - 10:36 pm
Regeneron
Evkeeza
Homozygous Familial Hypercholesterolemia
FDA
Sanofi/Regeneron's Libtayo Wins FDA Approval For A Type Of Skin Cancer
Yahoo/Benzinga
Wed, 02/10/21 - 10:32 am
Sanofi
Regeneron
Libtayo
FDA
advanced basal cell carcinoma
skin cancer
Regeneron has a winner in Dupixent and big sales hopes. So why are so few patients taking it?
Endpoints
Mon, 02/8/21 - 10:25 am
Dupixent
Regeneron
Sanofi
eczema
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »